Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.

Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in clearing the drug from the bloodstream.

Alternatively, renal clearance can be determined by multiplying the proportion of the bioavailable dose eliminated unchanged in the urine with the total body clearance. This method considers the fraction of the drug eliminated through the urinary route.

The noncompartmental formula can also be used to estimate renal clearance. This involves observing the amount of drug excreted unchanged in the urine and calculating the area under the curve, representing the drug's concentration-time profile in the body. By analyzing these parameters, renal clearance can be estimated.

The parameters mentioned earlier are evaluated during the dosing interval to calculate renal clearance under steady-state conditions. This allows for a more accurate determination of renal clearance in situations where drug concentrations are stable.

Another method involves considering the drug's mass balance cleared by the kidney and excreted through urine. Renal clearance can be calculated by quantifying the drug excreted in the urine and comparing it to the administered dose.

Advanced pharmacokinetic analyses employ data modeling and fitting with compartmental methods. These techniques require simultaneous modeling of observed systemic concentrations and excreted urinary amounts. By incorporating additional factors such as drug metabolism and distribution, these approaches provide a more comprehensive understanding of renal clearance. Understanding renal clearance is vital in pharmacology as it aids in determining drug dosing, predicting drug interactions, and assessing renal function.

Z rozdziału 6:

article

Now Playing

6.16 : Renal Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

26 Wyświetleń

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

44 Wyświetleń

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

67 Wyświetleń

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

34 Wyświetleń

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

43 Wyświetleń

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

26 Wyświetleń

article

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

28 Wyświetleń

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

34 Wyświetleń

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

24 Wyświetleń

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

24 Wyświetleń

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

12 Wyświetleń

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

11 Wyświetleń

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

19 Wyświetleń

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

29 Wyświetleń

article

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

25 Wyświetleń

See More

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone